Distalmotion Secures $200M to Democratize Robotic Surgery Worldwide

Distalmotion is thrilled to announce a remarkable milestone, having raised $200,000,000 to accelerate our mission of expanding access to advanced robotic surgery worldwide. Our innovative approach is driven by a clear vision: to deliver the substantial benefits of minimally invasive surgery to more surgeons, more hospitals, and more patients across the globe. This infusion of capital will not only fuel our commitment to disrupting traditional surgical paradigms but also drive the development and deployment of our flagship surgical robot, Dexter®. Designed with simplicity and efficiency in mind, Dexter® dismantles the complexities typically associated with robotic surgery, offering a modular, small-format open system that is both cost-effective and user-friendly. The raised funds will be strategically used to enhance our product development pipeline, streamline manufacturing processes, and broaden our market reach. We are dedicated to refining the Dexter® system, making it even more adaptable with its native compatibility with third-party 3D imaging systems, energy devices, and vessel sealers, ensuring its versatility in a wide range of surgical environments. Moreover, our suite of fully wristed, single-use instruments is set to redefine precision and dexterity, significantly reducing reprocessing requirements while boosting overall instrument performance. This financial boost empowers us to address the critical need for accessible robotic surgery solutions and to overcome the traditional barriers that have limited widespread adoption. At Distalmotion, we see this significant funding round as a stepping stone towards a new standard of care in minimally invasive surgery. With renewed vigor and resources, we are excited to propel our mission forward, improving patient outcomes and revolutionizing the way surgical care is delivered on a global scale.